venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogenic HSCT
Sica, S., venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogenic HSCT, <<BONE MARROW TRANSPLANTATION>>, 2026; (1): 101-103 [https://hdl.handle.net/10807/336066]
venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogenic HSCT
Sica, Simona
Ultimo
Membro del Collaboration Group
2026
Abstract
venetoclax plus hypomethylating agents as first salvage therapy for myeloid malignancies relapsing after allogenic HSCT
File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
